Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 16, 2021

View Archived Issues

Polymer-mediated "immunocloaking" - A new paradigm for combating transplant rejection?

Phase I trial begins for DVX-201 allogeneic NK cells in COVID-19 patients

Trial starts enrollment to assess LY-3361237 in patients with psoriasis

TYK2 inhibitor NDI-034858 enters phase II investigation for plaque psoriasis

MedImmune patents new ADCs for cancer

Kangpu Biopharmaceuticals divulges CRBN-binding isoindolines

Beijing Jacobio Pharmaceuticals presents new AURK1 inhibitors

Apeximmune Therapeutics describes anti-B7-H4 constructs for cancer

Primary endpoint not met in phase II trial of trimodulin in patients with severe COVID-19

Lomecel-B improves physical function in phase IIb study in patients with aging frailty

Phase I study of tyrosine kinase 2 inhibitor ICP-332 begins in China

Phase Ib data reported for ITPP in patients with hepatopancreatobiliary tumors

SPTBN1 genetic variants found to be associated with neurodevelopmental syndrome

Leptin linked to severity of COVID-19

Enanta's HBV treatment begins phase I study

LAVA Therapeutics cleared to initiate clinical trial of LAVA-1207

FDA lifts clinical hold on trial of Danon disease treatment RP-A501

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...